Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02849860 · ClinicalTrials.gov registry record · Phase 1
Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris
A Phase 1 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT02849860 is a Phase 1 study that has completed, run by Bausch Health Americas. The registered enrollment target is 20 participants.
The verdict
NCT02849860, a Phase 1 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Open-Label study designed to assess the safety and plasma PK of tretinoin and relevant metabolites after topical dermal application of IDP-121 lotion.
Interventions
- DRUG IDP-121 Lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02849860
The ClinicalTrials.gov registry entry for NCT02849860 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IDP-121 Lotion is the first listed.
NCT02849860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02849860 about?
NCT02849860 is a clinical study titled "Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris". Open-Label study designed to assess the safety and plasma PK of tretinoin and relevant metabolites after topical dermal application of IDP-121 lotion.
What is the current status of trial NCT02849860?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2014-02. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02849860?
The interventions under investigation include: IDP-121 Lotion (DRUG).
Who is sponsoring clinical trial NCT02849860?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.